With this background, here we present a review about the relationship between different common diseases, such as cardiovascular and neurological diseases, type 2 diabetes and cancer, which are associated with high levels of inflammation, with the activation of inflammasomes (essentially NLRP3) and the subsequent use of several nutraceutical compounds to target them. The gene discussed is NLRP3; the disease is type 2 diabetes mellitus.